HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis of postnatal rubella by the enzyme-linked immunosorbent assay for rubella IgM and IgG antibodies.

Abstract
A semi-automated enzyme-linked immunosorbent assay (ELISA) was established for the detection of rubella IgM antibodies in non-fractionated sera. A cut-off level between rubella IgM positive and negative sera was determined by a study of sera without rheumatoid factor from 200 blood donors. Testing of 12 donor sera containing rheumatoid factor showed that 5 sera gave a positive result in the rubella IgM assay. Rubella IgM antibodies were quantified by ELISA in a study of 214 serial serum specimens drawn from 16 patients with rubella during a period of up to 10 years after the infection. Peak values of the IgM antibodies were reached approximately 8 days after onset of the rash, and the persistence of the IgM antibodies ranged from 17-90 days, with the exception of one patient with a prolonged IgM response. The rubella IgG antibodies increased slowly after the rash and reached maximum levels about 50-120 days, after which a monor decrease was observed. The results of the present study indicate that ELISA is suitable as a routine procedure for the serodiagnosis of recent rubella.
AuthorsM Vejtorp, E Fanøe, J Leerhoy
JournalActa pathologica et microbiologica Scandinavica. Section B, Microbiology (Acta Pathol Microbiol Scand B) Vol. 87B Issue 3 Pg. 155-60 (Jun 1979) ISSN: 0105-0656 [Print] Denmark
PMID382737 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin G
  • Immunoglobulin M
  • Rheumatoid Factor
Topics
  • Acute Disease
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Humans
  • Immunoenzyme Techniques (methods)
  • Immunoglobulin G (analysis)
  • Immunoglobulin M (analysis)
  • Male
  • Rheumatoid Factor (analysis)
  • Rubella (diagnosis, immunology)
  • Ultracentrifugation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: